Actively Recruiting
Effects of Combined Intravenous-Inhalational Anesthesia Versus Inhalational Anesthesia on Postoperative Recovery in Gynecological Surgery Based on QoR-15 Scores
Led by Sakarya University · Updated on 2026-04-02
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of combined intravenous-inhalational anesthesia compared to inhalational anesthesia alone on recovery after elective gynecologic surgery. The study includes 100 patients aged 18 to 65 years classified as ASA physical status I to III. They will measure recovery using the Quality of Recovery-15 (QoR-15) questionnaire, which assesses physical comfort, emotional state, psychological support, pain, and daily activity ability. Higher scores reflect better recovery. Participants will be randomly assigned to receive either combined intravenous-inhalational anesthesia or inhalational anesthesia only during their surgery. Both groups will follow routine clinical practice for anesthetic drugs and doses. Postoperative recovery will be evaluated using the QoR-15 questionnaire on postoperative days 1 and 2. Secondary outcomes include pain scores at postoperative hours 6, 12, and 24, incidence of nausea and vomiting within 24 hours after surgery, and length of stay in the post-anesthesia care unit. During the study, patients will complete the QoR-15 questionnaire before surgery without knowing their anesthesia type and again on days 1 and 2 after surgery. Intraoperative data will be collected from anesthesia records. Researchers will monitor recovery quality, pain levels, nausea and vomiting occurrence, and care unit stay length to assess anesthesia impact. Participation lasts from pre-surgery through postoperative day 2, with monitoring up to 10 days for some outcomes.
CONDITIONS
Brief Title
Impact of Combined Intravenous-Inhalational vs Inhalational Anesthesia on QoR-15 Recovery Scores in Gynecologic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18-65 years
- Scheduled for elective gynecologic surgery at Sakarya University Faculty of Medicine Training and Research Hospital
- Classified as ASA physical status I, II, or III
- Able to understand and complete the QoR-15 questionnaire
- Provided written informed consent
You will not qualify if you...
- Severe comorbidities beyond ASA physical status III
- Advanced neurological disease or cognitive impairment
- Known allergy to anesthetic drugs used in the study
- Classified as ASA physical status IV or V
- Refusal to participate in the study
- Emergency or urgent surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day of surgery
Participants receive either combined intravenous-inhalational anesthesia or inhalational anesthesia only during elective gynecologic surgery, following routine clinical practice.
1 surgical visit (in-person)
Duration - 2 days
Participants' recovery is assessed using the Quality of Recovery-15 (QoR-15) questionnaire on postoperative days 1 and 2, along with monitoring of pain scores, nausea and vomiting, and length of stay in the post-anesthesia care unit.
Assessments on postoperative days 1 and 2 with additional monitoring up to 10 days
Trial Site Locations
Total: 1 location
1
Sakarya University Training and Research Hospital
Sakarya, Turkey (Türkiye), 54290
Actively Recruiting
Research Team
M
melike kar ünlü, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here